Anti-gp210 and anti-centromere antibodies are different risk factors for the progression of primary biliary cirrhosisMinoru Nakamura, Hiromi Ishibashi, Makiko Koyabu et al.|Hepatology|2006Cited by 365
Hepatocellular carcinoma in Japanese patients with nonalcoholic fatty liver disease and alcoholic liver disease: multicenter surveyKatsutoshi Tokushige, Etsuko Hashimoto, Hideyuki Hyogo et al.|Journal of Gastroenterology|2015Cited by 61
The impact of PNPLA3 and JAZF1 on hepatocellular carcinoma in non-viral hepatitis patients with type 2 diabetes mellitusMisuzu Ueyama, Sumio Watanabe, Nao Nishida et al.|Journal of Gastroenterology|2015Cited by 50
Machine learning for individualized prediction of hepatocellular carcinoma development after the eradication of hepatitis C virus with antiviralsTatsuya Minami, Ryosuke Tateishi, Masaya Sato et al.|Journal of Hepatology|2023Cited by 39
POGLUT1, the putative effector gene driven by rs2293370 in primary biliary cholangitis susceptibility locus chromosome 3q13.33Yuki Hitomi, Shuichi Kaneko, Kazuko Ueno et al.|Scientific Reports|2019Cited by 28